09.01.26 -- The Complex Anatomy Of An ADC Tech Transfer

Multi-product ATMP facilities need integrated teams, flexible design, and strategic HVAC to ensure scalability, contamination control, cost efficiency, and reliable long-term performance.

Evaluating fill-finish CDMOs beyond cost and capacity ensures long-term success. Strategic focus on technical depth, scalability, and modern compliance reduces risk.

To align with Annex 1 expectations, sponsors should focus on three key steps: understanding the guidelines, selecting the right partners, and futureproofing their manufacturing strategies.

Transparent, collaborative outsourcing reduces supply chain risk and protects IP. Open communication and proactive problem-solving keep development on track and speed commercialization.

Learn how to best align your development strategy, guide cross-functional decisions, and build a clear pathway from discovery to successful commercialization.

Biologics outsourcing is shifting to strategic partnerships focused on modality expertise, regulatory excellence, and integrated end-to-end capabilities.

Safe human cell line use needs key safety, identity, and purity testing steps at each cell bank stage. Robust assay plans assure full regulatory compliance, high safety, and product quality.

Complex biologics often outgrow traditional development platforms. Gain insight into how an integrated development strategy can accelerate timelines while reducing risk.